PFE vs XOM: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Exxon Mobil Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-19.
Pfizer Inc. · Healthcare
$27.64
+12.0% upside to fair value
Med Conviction
Grade B
VS
Exxon Mobil Corporation · Energy
$163.18
+10.3% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
PFE has more upside to fair value
(+12.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
XOM |
| Current Price |
$27.64 |
$163.18 |
| Fair Value Estimate |
$30.94 |
$179.98 |
| Upside to Fair Value |
+12.0%
|
+10.3%
|
| Market Cap |
$157.5B |
$676.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
17.4x
|
9.9x
|
| Price / Sales |
2.5x
|
1.9x
|
| Price / FCF |
14.3x
|
22.3x
|
| Revenue Growth YoY |
+2.6%
|
+44.1%
|
| Gross Margin |
71.3%
|
25.1%
|
| Operating Margin |
25.1%
|
10.7%
|
| Return on Equity |
4.9%
|
12.7%
|
| Dividend Yield |
6.22% |
2.52% |
| FCF Yield |
6.97%
|
4.49%
|
| Analyst Consensus |
Hold
|
Hold
|
Investment Thesis
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
Exxon Mobil is the largest integrated oil and gas major in the United States, operating across Upstream exploration and production, Downstream refining and fuels marketing, and Chemical manufacturing, with roughly 57,900 employees and a portfolio that spans conventional crude and natural gas, LNG, petrochemicals, and early-stage carbon capture, hydrogen, and biofuels ventures. The business qualit…
Accumulation Zones
| Metric |
PFE |
XOM |
| Zone Low |
$23.21 |
$134.98 |
| Zone High |
$26.30 |
$152.98 |
| In Buy Zone? |
No
|
No
|